52826 Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: Week 52 results of a multicenter, randomized, double-blind, placebo-controlled clinical study
Autor: | Sofen, Howard L., Gebauer, Kurt, Spelman, Lynda, Yamauchi, Paul S., Yao, Siu-Long, Kothekar, Mudgal, Nishandar, Tushar, Kopeloff, Iris, Crane, Michael, Gogineni, Ranga, Bagel, Jerry |
---|---|
Zdroj: | In Journal of the American Academy of Dermatology September 2024 91(3) Supplement:AB195-AB195 |
Databáze: | ScienceDirect |
Externí odkaz: |